Diet-induced obese (DIO) male rats were treated with (1) vehicle with ad libitum feeding (V), (2) CagriSema with ad libitum feeding (CS), (3) vehicle with pair-feeding matched to the caloric intake of the CS rats (PF) or (4) vehicle with caloric restriction to match the weight of the CS rats (weight matched (WM)) (Fig
GHK-CU (1 Vial) $29.99 $39.99Price range: $29.99 through $39.99 GHK-Cu (1 Vial) Research-grade copper tripeptide
Untreated Controls Preclinical injury models % reduction in healing time Tendon Transection (Rat Achilles model)50% Skin Wound Closure (Alkali burn model)45% Muscle Crush Injury (Rat quadriceps)40% Safety Data Safety Profile from Research What preclinical and early clinical studies report Preclinical Safety Summary LD50Not achieved Acute toxicityNone observed Chronic toxicityNone in 6-month studies Organ toxicityNone detected Human IV pilot (n=2)No adverse effects Cardiac/hepatic/renalNo effects detected Regulatory & Risk Considerations FDA statusUnapproved drug WADA statusBanned since 2022 (S0) Human trialsPhase 1 only Long-term effectsUnknown in humans Pro-angiogenic riskTheoretical unstudied Australia/NZPrescription only No lethal dose was reached in preclinical toxicology studies
The duration of protocols in studies varies from a few days to several weeks
Results showed that BPC 157 significantly accelerated the outgrowth of tendon explants
Exceptional Outcomes with B12 Injections Complement Semaglutide If you are also receiving weight loss injections, we add vitamin B12 to combat some of the symptoms you may experience, like nausea
